Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01057381 · ClinicalTrials.gov registry record · Phase 4

Dexmedetomidine in Pediatric Tonsillectomy

A Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy, sponsored by Baylor College of Medicine.

Completed
Registry status
Phase 4
Development phase
109
Enrollment target
1
Study location

NCT01057381 is a Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy that has completed, run by Baylor College of Medicine. The registered enrollment target is 109 participants, above the 98-participant average among 4 other Post Operative Analgesia trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01057381, a Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
Phase 4
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

Interventions

  • DRUG Dexmedetomidine 0.75 mcg/kg
  • DRUG Morphine 50 mcg/kg
  • DRUG Morphine 100 mcg/kg
  • DRUG Dexmedetomidine 1 mcg/kg

Study Locations (1)

Texas

  • Texas Children's Hospital, Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2005-08
Est. Completion 2010-12
Phase Phase 4

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT01057381

The ClinicalTrials.gov registry entry for NCT01057381 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 4 other Post Operative Analgesia trials with a reported enrollment target (11% higher). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Post Operative Analgesia appearing as the primary indexed condition, and to 4 interventions - of which Dexmedetomidine 0.75 mcg/kg is the first listed.

NCT01057381 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01057381 about?

NCT01057381 is a clinical study titled "Dexmedetomidine in Pediatric Tonsillectomy". The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

What is the current status of trial NCT01057381?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 109 participants. The study started on 2005-08. Estimated completion is 2010-12.

What conditions does trial NCT01057381 study?

This clinical trial studies the following conditions: Post Operative Analgesia, Pediatric Adenotonsillectomy.

What interventions are being tested in trial NCT01057381?

The interventions under investigation include: Dexmedetomidine 0.75 mcg/kg (DRUG), Morphine 50 mcg/kg (DRUG), Morphine 100 mcg/kg (DRUG), Dexmedetomidine 1 mcg/kg (DRUG).

Who is sponsoring clinical trial NCT01057381?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01057381 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Operative Analgesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.